Why is AIMN Stock Down Today?
Company Description
RONND Aimwell Partners (OTC Link: AIMN) is a publicly traded software - application company in the Technology sector. The company has a market capitalization of $7.5K.
AIMN stock has declined 45.5% over the past year. Shares last traded at $0.0300.
This page provides a comprehensive overview of AIMN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
RONND Aimwell Partners (AIMN) stock last traded at $0.0300, down 13.67% from the previous close. Over the past 12 months, the stock has lost 45.5%. At a market capitalization of $7.5K, AIMN is classified as a micro-cap stock with approximately 132.4K shares outstanding.
Latest News
RONND Aimwell Partners has 3 recent news articles, with the latest published today. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include AI. View all AIMN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AIMN Company Profile & Sector Positioning
RONND Aimwell Partners (AIMN) operates in the Software - Application industry within the broader Technology sector and is listed on the OTC Link.
Aimwell Bio (OTC pink:AIMN) announced expansion of Federated Health Intelligence Network (FHIN) engagement with U.S. hospitals, physician networks and initial dialogue in Australia, marking FHIN's first international footprint.
The company says FHIN offers a human-verified, source-traceable verification layer to validate AI-assisted recommendations, reduce malpractice exposure, and support structured pilot deployments with select institutions.